Influence of dietary components on the risk of gallstone formation
DOI:
https://doi.org/10.12775/JEHS.2024.65.014Keywords
diet, gallstones, gallbladder disease, risk factors, cholelithiasisAbstract
Gallbladder disease is a common condition in the population that has a negative impact on quality of life. The development of gallstones is influenced by both non-modifiable factors such as genetics, age, gender and modifiable risk factors including physical activity, body weight, diet. Dietary factors affecting the occurrence of the disease are difficult to capture in clinical studies, but the effect of certain substances on the development of gallstones has been proven. Positive risk factors include a high-calorie diet, obesity, increased intake of carbohydrates, saturated fatty acids, small amounts of fiber ingested. Moderate alcohol consumption reduces the risk of gallstones. Coffee may reduce the risk of the disease, but results are inconclusive. Inverse risk factors include consumption of monounsaturated fatty acids, consumption of nuts, olive oil, n-3 PUFA found in fish oil, vitamin C supplementation. No clear effect of consuming large amounts of dietary cholesterol can be established. The type of protein consumed also matters - vegetable protein reduces the risk of gallstones, animal protein has no such effect. Better understanding of dietary risks of cholelithiasis may help in future disease prevention.
References
Everhart JE, Ruhl CE. Burden of digestive diseases in the United States part I: overall and upper gastrointestinal diseases. Gastroenterology. 2009;136(2):376-386. doi:10.1053/j.gastro.2008.12.015
Portincasa P; Wang DQH Gallstones. In: Podolsky KD, Camilleri M, Fitz JG, Kalloo AN, Shanahan F, Wang TC, editors. Yamada’s Textbook of Gastroenterology. 6th ed. UK: Wiley-Blackwell; 2015. p. 1808–1834.
Portincasa P; Wang DQH Gallstones. In: Podolsky KD, Camilleri M, Fitz JG, Kalloo AN, Shanahan F, Wang TC, editors. Yamada’s Atlas of Gastroenterology. 5th ed. UK: Wiley-Blackwell; 2016. p. 335–353.
Sandler RS, Everhart JE, Donowitz M, et al. The burden of selected digestive diseases in the United States. Gastroenterology. 2002;122(5):1500-1511. doi:10.1053/gast.2002.32978
Everhart JE, Ruhl CE. Burden of digestive diseases in the United States Part III: Liver, biliary tract, and pancreas. Gastroenterology. 2009;136(4):1134-1144. doi:10.1053/j.gastro.2009.02.038
Amaral JF, Thompson WR. Gallbladder disease in the morbidly obese. Am J Surg. 1985;149(4):551-557. doi:10.1016/s0002-9610(85)80055-6
Lammert F, Gurusamy K, Ko CW, et al. Gallstones. Nat Rev Dis Primers. 2016;2:16024. Published 2016 Apr 28. doi:10.1038/nrdp.2016.24
Cuevas A, Miquel JF, Reyes MS, Zanlungo S, Nervi F. Diet as a risk factor for cholesterol gallstone disease. J Am Coll Nutr. 2004;23(3):187-196. doi:10.1080/07315724.2004.10719360
Hofmann AF. Primary and secondary prevention of gallstone disease: implications for patient management and research priorities. Am J Surg. 1993;165(4):541-548. doi:10.1016/s0002-9610(05)80958-4
Portincasa P, Moschetta A, Palasciano G. Cholesterol gallstone disease. Lancet. 2006;368(9531):230-239. doi:10.1016/S0140-6736(06)69044-2
Everhart JE, Khare M, Hill M, Maurer KR. Prevalence and ethnic differences in gallbladder disease in the United States. Gastroenterology. 1999;117(3):632-639. doi:10.1016/s0016-5085(99)70456-7
Wang DQ, Afdhal NH. Genetic analysis of cholesterol gallstone formation: searching for Lith (gallstone) genes. Curr Gastroenterol Rep. 2004;6(2):140-150. doi:10.1007/s11894-004-0042-1
Di Ciaula A, Wang DQ, Portincasa P. An update on the pathogenesis of cholesterol gallstone disease. Curr Opin Gastroenterol. 2018;34(2):71-80. doi:10.1097/MOG.0000000000000423
Di Ciaula A, Portincasa P. Recent advances in understanding and managing cholesterol gallstones. F1000Res. 2018;7:F1000 Faculty Rev-1529. Published 2018 Sep 24. doi:10.12688/f1000research.15505.1
Wang DQ, Cohen DE, Carey MC. Biliary lipids and cholesterol gallstone disease. J Lipid Res. 2009 Apr;50 Suppl(Suppl):S406-11. doi: 10.1194/jlr.R800075-JLR200. Epub 2008 Nov 17. PMID: 19017613; PMCID: PMC2674701.
Lammert F, Sauerbruch T. Mechanisms of disease: the genetic epidemiology of gallbladder stones. Nat Clin Pract Gastroenterol Hepatol. 2005;2(9):423-433. doi:10.1038/ncpgasthep0257
Stinton LM, Myers RP, Shaffer EA. Epidemiology of gallstones. Gastroenterol Clin North Am. 2010;39(2):157-vii. doi:10.1016/j.gtc.2010.02.003
Diehl AK. Epidemiology and natural history of gallstone disease. Gastroenterol Clin North Am. 1991;20(1):1-19.
Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL. Prospective study of abdominal adiposity and gallstone disease in US men. Am J Clin Nutr. 2004;80(1):38-44. doi:10.1093/ajcn/80.1.38
Grundy SM, Barnett JP. Metabolic and health complications of obesity. Dis Mon. 1990;36(12):641-731.
Tsunoda K, Shirai Y, Hatakeyama K. Prevalence of cholesterol gallstones positively correlates with per capita daily calorie intake. Hepatogastroenterology. 2004;51(59):1271-1274.
Compagnucci AB, Perroud HA, Batallés SM, et al. A nested case-control study on dietary fat consumption and the risk for gallstone disease. J Hum Nutr Diet. 2016;29(3):338-344. doi:10.1111/jhn.12332
Maclure KM, Hayes KC, Colditz GA, Stampfer MJ, Speizer FE, Willett WC. Weight, diet, and the risk of symptomatic gallstones in middle-aged women. N Engl J Med. 1989;321(9):563-569. doi:10.1056/NEJM198908313210902
Caroli-Bosc FX, Deveau C, Peten EP, et al. Cholelithiasis and dietary risk factors: an epidemiologic investigation in Vidauban, Southeast France. General Practitioner's Group of Vidauban. Dig Dis Sci. 1998;43(9):2131-2137. doi:10.1023/a:1018879819301
Ortega RM, Fernández-Azuela M, Encinas-Sotillos A, Andrés P, López-Sobaler AM. Differences in diet and food habits between patients with gallstones and controls. J Am Coll Nutr. 1997;16(1):88-95. doi:10.1080/07315724.1997.10718655
Ståhlberg D, Rudling M, Angelin B, et al. Hepatic cholesterol metabolism in human obesity. Hepatology. 1997;25(6):1447-1450. doi:10.1002/hep.510250623
Stokes CS, Lammert F. Excess Body Weight and Gallstone Disease. Visc Med. 2021;37(4):254-260. doi:10.1159/000516418
Banim PJ, Luben RN, Bulluck H, et al. The aetiology of symptomatic gallstones quantification of the effects of obesity, alcohol and serum lipids on risk. Epidemiological and biomarker data from a UK prospective cohort study (EPIC-Norfolk). Eur J Gastroenterol Hepatol. 2011;23(8):733-740. doi:10.1097/MEG.0b013e3283477cc9
Stender S, Nordestgaard BG, Tybjaerg-Hansen A. Elevated body mass index as a causal risk factor for symptomatic gallstone disease: a Mendelian randomization study. Hepatology. 2013;58(6):2133-2141. doi:10.1002/hep.26563
Shiffman ML, Sugerman HJ, Kellum JM, Moore EW. Changes in gallbladder bile composition following gallstone formation and weight reduction. Gastroenterology. 1992;103(1):214-221. doi:10.1016/0016-5085(92)91115-k
Palasciano G, Portincasa P, Vinciguerra V, et al. Gallstone prevalence and gallbladder volume in children and adolescents: an epidemiological ultrasonographic survey and relationship to body mass index. Am J Gastroenterol. 1989;84(11):1378-1382.
Kamrath RO, Plummer LJ, Sadur CN, et al. Cholelithiasis in patients treated with a very-low-calorie diet. Am J Clin Nutr. 1992;56(1 Suppl):255S-257S. doi:10.1093/ajcn/56.1.255S
Yang H, Petersen GM, Roth MP, Schoenfield LJ, Marks JW. Risk factors for gallstone formation during rapid loss of weight. Dig Dis Sci. 1992;37(6):912-918. doi:10.1007/BF01300390
Worobetz LJ, Inglis FG, Shaffer EA. The effect of ursodeoxycholic acid therapy on gallstone formation in the morbidly obese during rapid weight loss. Am J Gastroenterol. 1993;88(10):1705-1710.
Miller K, Hell E, Lang B, Lengauer E. Gallstone formation prophylaxis after gastric restrictive procedures for weight loss: a randomized double-blind placebo-controlled trial. Ann Surg. 2003;238(5):697-702. doi:10.1097/01.sla.0000094305.77843.cf
Liddle RA, Goldstein RB, Saxton J. Gallstone formation during weight-reduction dieting. Arch Intern Med. 1989;149(8):1750-1753.
Mathur A, Megan M, Al-Azzawi HH, et al. High dietary carbohydrates decrease gallbladder volume and enhance cholesterol crystal formation. Surgery. 2007;141(5):654-659. doi:10.1016/j.surg.2006.11.008
Biddinger SB, Haas JT, Yu BB, et al. Hepatic insulin resistance directly promotes formation of cholesterol gallstones. Nat Med. 2008;14(7):778-782. doi:10.1038/nm1785
Dubrac S, Parquet M, Blouquit Y, et al. Insulin injections enhance cholesterol gallstone incidence by changing the biliary cholesterol saturation index and apo A-I concentration in hamsters fed a lithogenic diet. J Hepatol. 2001;35(5):550-557. doi:10.1016/s0168-8278(01)00180-5
Misciagna G, Guerra V, Di Leo A, Correale M, Trevisan M. Insulin and gall stones: a population case control study in southern Italy. Gut. 2000 Jul;47(1):144-7. doi: 10.1136/gut.47.1.144. PMID: 10861277; PMCID: PMC1727980.
Chang Y, Sung E, Ryu S, Park YW, Jang YM, Park M. Insulin resistance is associated with gallstones even in non-obese, non-diabetic Korean men. J Korean Med Sci. 2008 Aug;23(4):644-50. doi: 10.3346/jkms.2008.23.4.644. PMID: 18756051; PMCID: PMC2526403.
Wong AC, Ko CW. Carbohydrate intake as a risk factor for biliary sludge and stones during pregnancy. J Clin Gastroenterol. 2013;47(8):700-705. doi:10.1097/MCG.0b013e318286fdb0
Tappy L, Lê KA. Metabolic effects of fructose and the worldwide increase in obesity. Physiol Rev. 2010;90(1):23-46. doi:10.1152/physrev.00019.2009
Jung S, Bae H, Song WS, Jang C. Dietary Fructose and Fructose-Induced Pathologies. Annu Rev Nutr. 2022 Aug 22;42:45-66. doi: 10.1146/annurev-nutr-062220-025831. PMID: 35995049; PMCID: PMC9904196.
Del Pozo Iribarren R, Mardones L, Villagrán M, et al. Effect of various dietary fructose concentrations on the gallstone formation process in mice. Efecto de diversas concentraciones de fructosa dietética en el proceso de formación de cálculos biliares en ratones. Nutr Hosp. 2024;41(1):194-201. doi:10.20960/nh.04610
Hou R, Panda C, Voruganti VS. Heterogeneity in Metabolic Responses to Dietary Fructose. Front Genet. 2019;10:945. Published 2019 Oct 31. doi:10.3389/fgene.2019.00945
Livesey G, Taylor R. Fructose consumption and consequences for glycation, plasma triacylglycerol, and body weight: meta-analyses and meta-regression models of intervention studies. Am J Clin Nutr. 2008;88(5):1419-1437. doi:10.3945/ajcn.2007.25700
Compagnucci AB, Perroud HA, Batallés SM, et al. A nested case-control study on dietary fat consumption and the risk for gallstone disease. J Hum Nutr Diet. 2016;29(3):338-344. doi:10.1111/jhn.12332
Misciagna G, Centonze S, Leoci C, et al. Diet, physical activity, and gallstones--a population-based, case-control study in southern Italy. Am J Clin Nutr. 1999;69(1):120-126. doi:10.1093/ajcn/69.1.120
Festi D, Colecchia A, Orsini M, et al. Gallbladder motility and gallstone formation in obese patients following very low calorie diets. Use it (fat) to lose it (well). Int J Obes Relat Metab Disord. 1998;22(6):592-600. doi:10.1038/sj.ijo.0800634
Tsai CJ, Leitzmann MF, Hu FB, Willett WC, Giovannucci EL. Frequent nut consumption and decreased risk of cholecystectomy in women. Am J Clin Nutr. 2004;80(1):76-81. doi:10.1093/ajcn/80.1.76
Tsai CJ, Leitzmann MF, Hu FB, Willett WC, Giovannucci EL. A prospective cohort study of nut consumption and the risk of gallstone disease in men. Am J Epidemiol. 2004;160(10):961-968. doi:10.1093/aje/kwh302
Linos AD, Daras V, Linos DA, Kekis V, Tsoukas MM, Golematis V. Dietary and other risk factors in the aetiology of cholelithiasis: a case control study. HPB Surg. 1989 Oct;1(3):221-7. doi: 10.1155/1989/56539. PMID: 2487388; PMCID: PMC2423534.
Yago MD, González V, Serrano P, et al. Effect of the type of dietary fat on biliary lipid composition and bile lithogenicity in humans with cholesterol gallstone disease. Nutrition. 2005;21(3):339-347. doi:10.1016/j.nut.2004.06.028
Boland LL, Folsom AR, Rosamond WD; Atherosclerosis Risk in Communities (ARIC) Study Investigators. Hyperinsulinemia, dyslipidemia, and obesity as risk factors for hospitalized gallbladder disease. A prospective study. Ann Epidemiol. 2002;12(2):131-140. doi:10.1016/s1047-2797(01)00260-5
Thornton J, Symes C, Heaton K. Moderate alcohol intake reduces bile cholesterol saturation and raises HDL cholesterol. Lancet. 1983;2(8354):819-822. doi:10.1016/s0140-6736(83)90738-9
Thornton JR, Heaton KW, Macfarlane DG. A relation between high-density-lipoprotein cholesterol and bile cholesterol saturation. Br Med J (Clin Res Ed). 1981;283(6303):1352-1354. doi:10.1136/bmj.283.6303.1352
Méndez-Sánchez N, González V, Aguayo P, et al. Fish oil (n-3) polyunsaturated fatty acids beneficially affect biliary cholesterol nucleation time in obese women losing weight. J Nutr. 2001;131(9):2300-2303. doi:10.1093/jn/131.9.2300
Berr F, Holl J, Jüngst D, et al. Dietary N-3 polyunsaturated fatty acids decrease biliary cholesterol saturation in gallstone disease. Hepatology. 1992;16(4):960-967. doi:10.1002/hep.1840160418
Jonkers IJ, Smelt AH, Ledeboer M, et al. Gall bladder dysmotility: a risk factor for gall stone formation in hypertriglyceridaemia and reversal on triglyceride lowering therapy by bezafibrate and fish oil. Gut. 2003;52(1):109-115. doi:10.1136/gut.52.1.109
Caroli-Bosc FX, Deveau C, Peten EP, et al. Cholelithiasis and dietary risk factors: an epidemiologic investigation in Vidauban, Southeast France. General Practitioner's Group of Vidauban. Dig Dis Sci. 1998;43(9):2131-2137. doi:10.1023/a:1018879819301
Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL. Long-term intake of trans-fatty acids and risk of gallstone disease in men. Arch Intern Med. 2005;165(9):1011-1015. doi:10.1001/archinte.165.9.1011
Misciagna G, Centonze S, Leoci C, et al. Diet, physical activity, and gallstones--a population-based, case-control study in southern Italy. Am J Clin Nutr. 1999;69(1):120-126. doi:10.1093/ajcn/69.1.120
Lee DW, Gilmore CJ, Bonorris G, et al. Effect of dietary cholesterol on biliary lipids in patients with gallstones and normal subjects. Am J Clin Nutr. 1985;42(3):414-420. doi:10.1093/ajcn/42.3.414
Cuevas A, Miquel JF, Reyes MS, Zanlungo S, Nervi F. Diet as a risk factor for cholesterol gallstone disease. J Am Coll Nutr. 2004;23(3):187-196. doi:10.1080/07315724.2004.10719360
Tehrani AN, Saadati S, Yari Z, et al. Dietary fiber intake and risk of gallstone: a case-control study. BMC Gastroenterol. 2023;23(1):119. Published 2023 Apr 11. doi:10.1186/s12876-023-02752-0
Ortega RM, Fernández-Azuela M, Encinas-Sotillos A, Andrés P, López-Sobaler AM. Differences in diet and food habits between patients with gallstones and controls. J Am Coll Nutr. 1997;16(1):88-95. doi:10.1080/07315724.1997.10718655
European Association for the Study of the Liver (EASL). Electronic address: easloffice@easloffice.eu. EASL Clinical Practice Guidelines on the prevention, diagnosis and treatment of gallstones. J Hepatol. 2016;65(1):146-181. doi:10.1016/j.jhep.2016.03.005
Zhang JW, Xiong JP, Xu WY, et al. Fruits and vegetables consumption and the risk of gallstone diasease: A systematic review and meta-analysis. Medicine (Baltimore). 2019;98(28):e16404. doi:10.1097/MD.0000000000016404
Bergman F, Curstedt T, Eriksson H, van der Linden W, Sjövall J. Gallstone formation in guinea pigs under different dietary conditions. Effect of vitamin C on bile acid pattern. Med Biol. 1981;59(2):92-98.
Ginter E. Cholesterol: vitamin C controls its transformation to bile acids. Science. 1973;179(4074):702-704. doi:10.1126/science.179.4074.702
Simon JA, Hudes ES. Serum ascorbic acid and other correlates of gallbladder disease among US adults. Am J Public Health. 1998;88(8):1208-1212. doi:10.2105/ajph.88.8.1208
Ortega RM, Fernández-Azuela M, Encinas-Sotillos A, Andrés P, López-Sobaler AM. Differences in diet and food habits between patients with gallstones and controls. J Am Coll Nutr. 1997;16(1):88-95. doi:10.1080/07315724.1997.10718655
Simon JA, Grady D, Snabes MC, Fong J, Hunninghake DB. Ascorbic acid supplement use and the prevalence of gallbladder disease. Heart & Estrogen-Progestin Replacement Study (HERS) Research Group. J Clin Epidemiol. 1998;51(3):257-265. doi:10.1016/s0895-4356(97)80280-6
Gustafsson U, Wang FH, Axelson M, Kallner A, Sahlin S, Einarsson K. The effect of vitamin C in high doses on plasma and biliary lipid composition in patients with cholesterol gallstones: prolongation of the nucleation time. Eur J Clin Invest. 1997;27(5):387-391. doi:10.1046/j.1365-2362.1997.1240670.x
Attili AF, Scafato E, Marchioli R, Marfisi RM, Festi D. Diet and gallstones in Italy: the cross-sectional MICOL results. Hepatology. 1998;27(6):1492-1498. doi:10.1002/hep.510270605
Pixley F, Wilson D, McPherson K, Mann J. Effect of vegetarianism on development of gall stones in women. Br Med J (Clin Res Ed). 1985;291(6487):11-12. doi:10.1136/bmj.291.6487.11
Pradhan SB, Joshi MR, Vaidya A. Prevalence of different types of gallstone in the patients with cholelithiasis at Kathmandu Medical College, Nepal. Kathmandu Univ Med J (KUMJ). 2009;7(27):268-271. doi:10.3126/kumj.v7i3.2736
Maclure KM, Hayes KC, Colditz GA, Stampfer MJ, Willett WC. Dietary predictors of symptom-associated gallstones in middle-aged women. Am J Clin Nutr. 1990;52(5):916-922. doi:10.1093/ajcn/52.5.916
Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL. Dietary protein and the risk of cholecystectomy in a cohort of US women: the Nurses' Health Study. Am J Epidemiol. 2004;160(1):11-18. doi:10.1093/aje/kwh170
Scragg RK, McMichael AJ, Baghurst PA. Diet, alcohol, and relative weight in gall stone disease: a case-control study. Br Med J (Clin Res Ed). 1984;288(6424):1113-1119. doi:10.1136/bmj.288.6424.1113
Lander EM, Wertheim BC, Koch SM, Chen Z, Hsu CH, Thomson CA. Vegetable protein intake is associated with lower gallbladder disease risk: Findings from the Women's Health Initiative prospective cohort. Prev Med. 2016;88:20-26. doi:10.1016/j.ypmed.2016.03.016
Stender S, Nordestgaard BG, Tybjaerg-Hansen A. Elevated body mass index as a causal risk factor for symptomatic gallstone disease: a Mendelian randomization study. Hepatology. 2013;58(6):2133-2141. doi:10.1002/hep.26563
Misciagna G, Leoci C, Guerra V, et al. Epidemiology of cholelithiasis in southern Italy. Part II: Risk factors. Eur J Gastroenterol Hepatol. 1996;8(6):585-593. doi:10.1097/00042737-199606000-00017
Leitzmann MF, Willett WC, Rimm EB, et al. A prospective study of coffee consumption and the risk of symptomatic gallstone disease in men. JAMA. 1999;281(22):2106-2112. doi:10.1001/jama.281.22.2106
Leitzmann MF, Stampfer MJ, Willett WC, Spiegelman D, Colditz GA, Giovannucci EL. Coffee intake is associated with lower risk of symptomatic gallstone disease in women. Gastroenterology. 2002;123(6):1823-1830. doi:10.1053/gast.2002.37054
Walcher T, Haenle MM, Mason RA, et al. The effect of alcohol, tobacco and caffeine consumption and vegetarian diet on gallstone prevalence. Eur J Gastroenterol Hepatol. 2010;22(11):1345-1351. doi:10.1097/MEG.0b013e32833efdb2
Kratzer W, Kächele V, Mason RA, et al. Gallstone prevalence in relation to smoking, alcohol, coffee consumption, and nutrition. The Ulm Gallstone Study. Scand J Gastroenterol. 1997;32(9):953-958. doi:10.3109/00365529709011208
Halvorsen B, Ranheim T, Nenseter MS, Huggett AC, Drevon CA. Effect of a coffee lipid (cafestol) on cholesterol metabolism in human skin fibroblasts. J Lipid Res. 1998;39(4):901-912.
Brown SR, Cann PA, Read NW. Effect of coffee on distal colon function. Gut. 1990;31(4):450-453. doi:10.1136/gut.31.4.450
Nordenvall C, Oskarsson V, Wolk A. Inverse association between coffee consumption and risk of cholecystectomy in women but not in men. Clin Gastroenterol Hepatol. 2015;13(6):1096-1102.e1. doi:10.1016/j.cgh.2014.09.029
Hannuksela ML, Rantala M, Kesäniemi YA, Savolainen MJ. Ethanol-induced redistribution of cholesteryl ester transfer protein (CETP) between lipoproteins. Arterioscler Thromb Vasc Biol. 1996;16(2):213-221. doi:10.1161/01.atv.16.2.213
Gaziano JM, Buring JE, Breslow JL, et al. Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction. N Engl J Med. 1993;329(25):1829-1834. doi:10.1056/NEJM199312163292501
Haskell WL, Camargo C Jr, Williams PT, et al. The effect of cessation and resumption of moderate alcohol intake on serum high-density-lipoprotein subfractions. A controlled study. N Engl J Med. 1984;310(13):805-810. doi:10.1056/NEJM198403293101301
Thornton J, Symes C, Heaton K. Moderate alcohol intake reduces bile cholesterol saturation and raises HDL cholesterol. Lancet. 1983;2(8354):819-822. doi:10.1016/s0140-6736(83)90738-9
Probert CS, Emmett PM, Heaton KW. Some determinants of whole-gut transit time: a population-based study. QJM. 1995;88(5):311-315.
Cha BH, Jang MJ, Lee SH. Alcohol Consumption Can Reduce the Risk of Gallstone Disease: A Systematic Review with a Dose-Response Meta-Analysis of Case-Control and Cohort Studies. Gut Liver. 2019;13(1):114-131. doi:10.5009/gnl18278
Basso L, McCollum PT, Darling MR, Tocchi A, Tanner WA. A descriptive study of pregnant women with gallstones. Relation to dietary and social habits, education, physical activity, height, and weight. Eur J Epidemiol. 1992;8(5):629-633. doi:10.1007/BF00145375
Fornari F, Imberti D, Squillante MM, et al. Incidence of gallstones in a population of patients with cirrhosis. J Hepatol. 1994;20(6):797-801. doi:10.1016/s0168-8278(05)80152-7
Conte D, Fraquelli M, Fornari F, Lodi L, Bodini P, Buscarini L. Close relation between cirrhosis and gallstones: cross-sectional and longitudinal survey. Arch Intern Med. 1999;159(1):49-52. doi:10.1001/archinte.159.1.49
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Marcelina Sawczuk, Jakub Ptak, Marek Miśkiewicz, Jagoda Marcinkowska, Jakub Perłowski, Victoria Teska, Karolina Koczkodon, Rafał Noga, Mariusz Krompiewski, Adrian Herc
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 268
Number of citations: 0